Disease |
Pathology |
Inheritance |
Age of onset of primary manifestation |
Cardiac involvement (%) |
Potential phenotype |
Common/typical conduction disturbances/arrhythmias |
LGE |
Fat/Water |
Duchenne muscular dystrophy |
Dystrophinopathy |
X-linked recessive |
3–5 years |
Up to 90 [2] |
DCM |
Sinus tachycardia, ventricular tachycardias |
+ |
+ |
Becker muscular dystrophy |
Dystrophinopathy |
X-linked recessive |
6–20 (variable) |
60–70 [3] |
DCM |
AV nodal and bundle branch blocks |
+ |
No data |
Emery-Dreifuss muscular dystrophy |
Nuclear envelopathies, laminopathies |
X-linked recessive, autosomal dominant or recessive |
10–20 years |
50–90 (highly variable) [4] |
DCM, HCM, LVNC, biatrial dilation |
Bradycardias (AV blocks), tachycardias (SVTs) |
Rare, if present associated with tachycardias |
Rare |
Limb girdle muscular dystrophy |
Calpainopathies, sarcoglycanopathies, etc. |
Autosomal dominant or recessive |
5-20 |
25–90 [5] |
DCM, HCM |
SVTs, VTs |
+ |
+ |
Myofibrillar myopathy |
Desminopathy, etc. |
Autosomal dominant (other forms exist) |
2–50 (highly variable) |
15–30 [6] |
DCM, HCM, LVNC |
Complete AV block |
No data |
No data |
Facioscapulohumeral muscular dystrophy |
DUX/SMCHD1 gene |
Autosomal dominant (other forms exist) |
0–20 |
5–15 [7] |
DCM (rare) |
RBBB, SVTs |
+ |
+ |
Myotonic dystrophy type 1 |
DMPK gene |
Autosomal dominant |
0–50 (highly variable) |
60–80 [8] |
DCM, HCM |
AV Blocks, QTc/QRS prolongation, VES, Afib, Aflatter, RBBB/LBBB, VTs |
+ |
No data |
Myotonic dystrophy type 2 |
ZNF-9 gene |
Autosomal dominant |
30–50 |
Up to 25 [9] |
DCM, HCM |
Afib |
+ |
+ |